Q4 2016 Holdings
Filed 2017-02-14 | 57 holdings | $12.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $139 | 14,000 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $216 | 11,478 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $232 | 2,135 | 0.0% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $232 | 13,907 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $238 | 6,137 | 0.0% |
| Avexis Inc | COM | 05366U100 | $239 | 5,000 | 0.0% |
| Intrexon Corp | COM | 46122T102 | $240 | 9,875 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $241 | 5,367 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $244 | 3,408 | 0.0% |
| BIO Techne Corp(TECH) | COM | 09073M104 | $254 | 2,467 | 0.0% |
| Quintiles Transnatio Hldgs I | COM | 74876Y101 | $260 | 3,418 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $263 | 2,589 | 0.0% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $267 | 16,613 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $271 | 38,947 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $280 | 1,951 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $322 | 40,000 | 0.0% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $448 | 14,300 | 0.0% |
| Contrafect Corporation(CFRXEUR) | COM | 212326102 | $525 | 300,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $561 | 25,000 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $764 | 10,864 | 0.0% |
| New SR Invt Group Inc | COM | 648691103 | $819 | 83,700 | 0.0% |
| Medicines Co | COM | 584688105 | $950 | 28,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.0K | 60,000 | 0.0% |
| Lilly ELI & Co(LLY)Call | CALL | 532457108 | $1.1K | 15,000 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $1.2K | 80,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $1.3K | 30,000 | 0.0% |
| Tesaro Inc CMN | COM | 881569107 | $1.3K | 10,000 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $1.6K | 50,000 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $2.3K | 184,328 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $2.3K | 60,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $2.4K | 18,967 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.5K | 33,357 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | CALL | 110122108 | $2.6K | 45,000 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $2.7K | 18,743 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $2.8K | 7,684 | 0.0% |
| Mettler Toledo International(MTD) | COM | 592688105 | $3.0K | 7,188 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $3.1K | 24,973 | 0.0% |
| Qiagen NV(QGEN) | REG SHS | N72482107 | $3.1K | 111,683 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $3.2K | 27,286 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $3.3K | 120,000 | 0.0% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $3.4K | 85,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $3.5K | 35,031 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $3.6K | 68,310 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.6K | 112,300 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $3.7K | 77,550 | 0.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $4.6K | 82,296 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $4.9K | 83,700 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $5.3K | 90,000 | 0.0% |
| Ishares TR(IBB) | NASDQ BIOTEC ETF | 464287556 | $6.6K | 25,000 | 0.1% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $7.7K | 130,000 | 0.1% |